AbbVie

YTD

ALL

Trade AbbVie 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.

CEO

Robert A. Michael

CEORobert A. Michael

Employees

55,000

Employees55,000

Headquarters

North Chicago, Illinois

HeadquartersNorth Chicago, Illinois

Founded

2011

Founded2011

Employees

55,000

Employees55,000

ABBV Key Statistics

Market cap

336.35B

Market cap336.35B

Price-Earnings ratio

81.05

Price-Earnings ratio81.05

Dividend yield

3.36%

Dividend yield3.36%

Average volume

7.70M

Average volume7.70M

High today

$192.69

High today$192.69

Low today

$176.56

Low today$176.56

Open price

$181.17

Open price$181.17

Volume

12.79M

Volume12.79M

52 Week high

$218.66

52 Week high$218.66

52 Week low

$153.58

52 Week low$153.58

ABBV News

Simply Wall St 22h

AbbVie First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Advertisement AbbVie ( ) First Quarter 2025 Results Key Financial Results Revenue: US$13.3b (up 8.4% from 1Q 2024). Net income: US$1.28b (down 6.1% from 1Q...

Analyst ratings

63%

of 30 ratings

Buy

63.3%

Hold

33.3%

Sell

3.3%

People also own

Based on the portfolios of people who own ABBV. This list is generated using Robinhood data, and it’s not a recommendation.